Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
doi:10.1002/fsn3.807 [98] Kkemre Aydn B, Yldz M, Akgn A, Topal N, Adal E, nal H
10.1021/acschemneuro.6b00362 ACS Chem
A vial label may show the concentration, while your treatment plan may describe the amount used at each administration
Rituximab Rituximab is a monoclonal anti-CD20 antibody used for the treatment of hematooncological malignancies originating from CD20-expressing B-cells, such as chronic lymphocytic leukemia (CLL), diffuse large B cell lymphoma, follicular lymphoma, or for selected autoimmune diseases (rheumatoid arthritis or systemic lupus erythematosus) (137139)
Research on 5-Amino-1MQ is still emerging, but preclinical studies suggest it has a good safety profile when used properly
Sci Rep 10(1):17078
US$ 22.57
US$ 20.01
US$ 21.09
US$ 27.61
US$ 29.32
US$ 27.14
